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Open access under The present study aimed to evaluate the effect of methyl-b-cyclodextrin (MbCD) as a cholesterol loader to
change oocyte plasma membrane and increase its tolerance toward cryopreservation. The ﬁrst and sec-
ond experiments were conducted to investigate if MbCD could improve nuclear and cytoplasmic matu-
ration after oocyte exposure to cold stress for 10 or 30 min, respectively. No differences (P > 0.05) in
either experiment in the metaphase II (MII) rate of oocytes exposed to MbCD and cold stress; but these
oocytes presented lower maturation rates than control groups. In the second experiment, a lower per-
centage of oocytes showed degenerated chromatin (P < 0.05) after exposure to 2 mg/mL of MbCD com-
pared to the group exposed to 0 mg/mL. However, no differences among treatments were observed in
cytoplasmic maturation. Groups exposed to cold stress demonstrated a lower (P < 0.05) capacity for
embryonic development compared to the control groups. In the third experiment immature oocytes were
exposed to MbCD and then, vitriﬁed (cryotop). After warming, we observed that the ability to reach MII
and chromatin degeneration were altered (P < 0.05) by MbCD. The blastocysts rate (P < 0.05) on D7 was
higher in the 2 mg/mL MbCD group, but an identical ﬁnding was not observed on D8 (P > 0.05). Chroma-
tin degeneration was higher in the vitriﬁcation groups. We conclude that MbCD improved nuclear mat-
uration by reducing oocyte degeneration after cold stress or vitriﬁcation; however, more studies are
required to clarify the usefulness of MbCD use in oocyte cryopreservation.
 2012 Elsevier Inc. Open access under the Elsevier OA license. Introduction
The ability to preserve the female gamete is becoming an inte-
gral part of assisted reproductive techniques (ARTs) as it increases
the availability of oocytes for use in such techniques. Successful
cryopreservation of the oocyte would allow for the preservation
of genetic resources of farm and wild animals as well as the pres-
ervation of gametes of women with premature loss of ovarian
function. However, because of their large size and marked sensitiv-
ity to cooling, the cryopreservation of oocytes is very difﬁcult in
most mammals.
Up to now, the standard method used to cryopreserve mamma-
lian oocytes has been slow freezing, which includes slow coolingby Brazilian Governmental
ch Corporation) and CNPq,
velopment).
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the Elsevier OA license. rates and low concentrations of cryoprotectants agents. Vitriﬁca-
tion, which uses rapid cooling rates and a very high concentration
of cryoprotectants to prevent the formation of ice crystals, usually
replaces slow freezing. This method has been utilized in several
species of domestic animals, such as sheep [7], horses [34], cats
[16] and cattle [21,33]. However, the overall success of the oocytes
in developing to the blastocyst stage is still very low.
Multiple attempts have been made for improving the efﬁciency
of oocyte vitriﬁcation by maximizing the cooling rate and minimiz-
ing the cryoprotectant concentration. One approach for achieving a
rapid cooling rate is to reduce the volume of the vitriﬁcation solu-
tion. In this regard, various methods have been proposed, initially
MDS was developed by Arav in 1992 [28], and then many other de-
vices were developed such as Open Pulled Straw (OPS) [35], cryo-
loop [13], hemi-straw [37] and cryotop [12]. Among these
methods, cryotop uses a very small amount of vitriﬁcation solution
and is reportedly more practical and efﬁcient for cryopreserving
bovine oocytes [21,22]. Even with the advantages of the cryotop
method compared to others, the results obtained with vitriﬁcation
of bovine oocytes remain unsatisfactory [5,19,21,22,42].
The cell damage that occurs during cryopreservation is caused
by several factors, such as osmotic stress, toxicity of the
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damage to cellular organelles [29] and direct chilling injury
(DCI). Chilling injuries trigger the destabilization of cell mem-
branes during the thermotropic phase transition from the ﬂuid
phase to the gel phase during the cooling process, which is consid-
ered one of the major obstacles to the success of cryopreservation
of oocytes [3,27].
Irreversible damage to membrane integrity caused by chilling
during the lipid phase transition is directly related to the quantity
of lipids present [3]. Cholesterol is a major structural lipid constit-
uent of the membrane and regulates its function. Therefore, the
cholesterol/phospholipid ratio is a vital determinant of plasma
membrane ﬂuidity and stability during cryopreservation [10].
Membranes with high concentrations of cholesterol are more ﬂuid
at low temperatures and consequently more resistant to damage
during cooling [40,41]. To increase membrane ﬂuidity and perme-
ability at low temperatures, cholesterol can be added to the plasma
membrane, thereby providing an alternative method for increasing
oocyte tolerance for cryopreservation.
Cyclodextrins can act as carrier molecules for the incorporation
of cholesterol into plasma membranes [1,10,25]. Cyclodextrins are
water-soluble cyclic oligosaccharides consisting of glucose units
(a-D-glucopyranoside) joined by connections typea-1,4 that con-
tain a hydrophobic center capable of integrating lipids. Due to its
structure, free cyclodextrin can selectively deplete cholesterol
from isolated or intact membranes from a variety of cells, including
spermatozoa and oocytes [23], whereas cyclodextrins preloaded
with cholesterol deliver cholesterol to the plasma membrane.
Therefore, this simple approach can be used prior to cryopreserva-
tion to change the membrane composition and minimize mem-
brane damage.
Methyl-b-cyclodextrin (MbCD) is the most potent cyclodextrin
family member with respect to its afﬁnity for cholesterol binding.
Moreover, it was showed that cholesterol improve bovine [1,25]
and equine [20] sperm viability after cryopreservation [23].
One study demonstrated that cholesterol carried by cyclodex-
trin entered cumulus cells and oocytes, which improved the sur-
vival of vitriﬁed mature bovine oocytes [10]. No further studies
have investigated this simple approach to reduce oocyte cold
sensitivity.
In the present study, we used MbCD to load cholesterol from fe-
tal calf serum (FCS) and deliver it to the oocyte plasma membrane.
The purpose of this study was to investigate the effect of MbCD
exposure on the in vitro maturation rates and developmental abil-
ity of cold-stressed as well as vitriﬁed immature bovine oocytes.Materials and methods
Chemicals and supplies
Unless otherwise indicated, chemicals were purchased from
Sigma (St. Louis, MO, USA). Cryotop devices were purchased from
Ingámed (Maringá, PR, Brazil).Oocyte recovery
Ovaries from crossbred cows (Bos indicus  Bos taurus) were
collected immediately after slaughter and transported to the labo-
ratory in saline solution (0.9% NaCl) supplemented with penicillin
G (100 IU/mL) and streptomycin sulfate (100 g/mL) at 35 C.
Cumulus oocyte complexes (COCs) were aspirated from 3- to
8-mm diameter follicles with an 18-gauge needle and pooled in a
15-mL conical tube. After 10 min, COCs were recovered and
selected in holding medium consisted by HEPES-buffered TCM-
199 (GIBCO BRL) supplemented with 10% FCS. Only COCs withhomogenous cytoplasm and at least three layers of cumulus cells
were used in the experiments.
Cholesterol-loaded methyl-b-cyclodextrin (MbCD) preparation
In a glass tube, a stock solution (SS) with 1 g of methyl-b-cyclo-
dextrin was dissolved in 2 mL of methanol and stored at 20 C
[10]. To load cholesterol from FCS, the SS was diluted with different
concentrations (1, 2 or 3 mg) of MbCD in 1 mL of HEPES-buffered
TCM-199 (GIBCO BRL) supplemented with 20% FCS. The solution
was incubated overnight at 38.5 C.
Vitriﬁcation and warming
Oocyte vitriﬁcation was performed as previously described [12]
with slight modiﬁcations. The holding medium (HM), which was
used to handle oocytes during vitriﬁcation and warming, was com-
posed of HEPES-buffered TCM-199 (GIBCO BRL) supplemented
with 20% FCS. For vitriﬁcation, groups were ﬁrst washed three
times in an equilibrium solution composed of 7.5% ethylene glycol
and 7.5% dimethylsulfoxide (Me2SO) dissolved in HM for a total of
9 min. Oocytes were transferred to a vitriﬁcation solution of 15%
ethylene glycol, 15% Me2SO and 0.5 M of sucrose in HMwhere they
were incubated for 45–60 s. Next, the oocytes were placed into the
cryotop device in sets of 3–5 under a stereomicroscope. Before vit-
riﬁcation, most of the solution that was transferred with the oo-
cytes was removed from the device, and only a thin layer
(<0.1 ll) remained to cover the oocytes. Subsequently, the cryotop
device was immediately submerged into liquid nitrogen. Warming
was performed immediately after vitriﬁcation by immersing the
cryotop end into a drop of HM supplemented with 1 M of sucrose
for 1 min pre-warmed at 37 C. The oocytes were transferred to
HM medium supplemented with 0.5 M of sucrose for 3 min,
respectively, and ﬁnally to the original holding medium. After-
wards, the oocytes were placed in the culture dishes to mature
or were ﬁxed for maturational stage evaluation.
Oocyte maturation and assessment of meiotic progression
After warming, COCs were washed and transferred (groups of
25–30) to a 200 lL drop of maturation medium under silicone oil
and incubated for 22 h at 39 C in 5% CO2 in air. The maturation
medium was TCM-199 supplemented with 10% FCS (v/v), 10 mg/
mL of FSH and antibiotics (100 IU/mL of penicillin and 50 mg/mL
of streptomycin). CCOs were distributed into 4 groups, each group
represented one maturation period. The ﬁrst one was ﬁxed imme-
diately after selection, before IVM; the second group was ﬁxed
with 8 h of IVM; the third was ﬁxed 22 h of IVM and the fourth
group completed IVM period and was ﬁxed with 24 h of IVM.
For meiotic progression evaluation, oocytes were denuded and
ﬁxed for at least 48 h with acetic alcohol (1:3). On the day of the
evaluation, these oocytes were placed on a slide, covered with a
coverslip and were stained with 1% lacmoid in 45% glacial acetic
acid. The maturational stage of each oocyte was determined using
phase contrast microscopy. Oocytes were classiﬁed as follows:
immature – did not reach metaphase II; mature – showed meta-
phase II plate; abnormal – any chromosomal aberrations (diploid,
abnormal metaphase II, multidirectional spindle, chromosomal
dispersion); degenerate – diffuse or undeﬁned chromatin.
In vitro fertilization (IVF) and embryo culture (IVC)
Following maturation, COCs (groups of 25–30) were transferred
to a 200-lL drop of fertilization medium. For fertilization, frozen
semen from a Nelore bull previously tested in the lab for IVF was
used. Motile spermatozoa were obtained by the Percoll method
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tration of 1  106 spermatozoa mL1. The fertilization mediumwas
TALP [24] supplemented with penicillamine (2 mM), hypotaurine
(1 mM), epinephrine (250 mM) and heparin (10 lg/mL1). Sperma-
tozoa and oocytes were co-incubated for 18 h at 39 C with 5% CO2
in air, and the day of in vitro insemination was considered as day 0.
Eighteen hours post insemination (pi), presumptive zygotes
were washed, transferred to 200-lmL drops of synthetic oviduct
ﬂuid medium with amino acids, citrate and inositol (SOFaaci; [9]
supplemented with 5% FCS. This medium was incubated at 39 C
with 5% CO2 in air.
Embryos were evaluated on day 2 pi for cleavage and on days 6,
7 and 8 pi for blastocyst rates.
Assessment of fertilization rate
To evaluate the fertilization rate, oocytes were removed from
culture 18 h pi, ﬁxed with acetic acid: alcohol (1:3), and stained
with a 1% solution of lacmoid in 45% glacial acetic acid. Cells were
examined under a phase contrast microscope (Nikon Eclipse E200,
1000) and classiﬁed as either (a) non fertilized – presence of fe-
male and absence of male chromatin; (b) fertilized – presence of
female and sperm chromatin in the cytoplasm, decondensed sperm
head, pronuclei or cleaved; (c) degenerated; or (d) abnormal.
Experimental design
Experiment 1. The effects of different MbCD concentrations on
the in vitro maturation and development of immature bovine oo-
cytes submitted to cold stress for 10 min.
In this experiment, a total of 1452 COCs were distributed into
six treatments (T) as follows: (T1) control: untreated COCs; (T2)
0 MbCD: COCs were incubated for 1 h without MbCD and exposed
to 4 C for 10 min; (T3) 1 MbCD: COCs were incubated for 1 h in the
presence of 1 mg/mL of MbCD and exposed to 4 C for 10 min; (T4)
2 MbCD: COCs were incubated for 1 h in the presence of 2 mg/mL
of MbCD and exposed to 4 C for 10 min; (T5) 3 MbCD: COCs were
incubated for 1 h in the presence of 3 mg/mL of MbCD and exposed
to 4 C for 10 min; (T6) bench control: COCs remained at room
temperature for the same amount of time as the treated groups.
Following all treatments, oocytes were transferred to maturation
medium.
After maturation, oocytes were either ﬁxed for evaluation of nu-
clear staining or fertilized in vitro for culturing until the blastocyst
stage. For all treatments embryos were evaluated on D2, D6, D7
and D8 pi to determine cleavage and blastocyst rates.
Experiment 2. The effects of MbCD on the response of bovine
immature oocytes to longer durations of cold stress.
We found in experiment 1 that there were no differences among
the groups treated with the various concentrations of MbCD. Thus,
we decided to expose oocytes to 2 mg/mL of MbCD for longer stints
of cold stress. A total of 966 COCs were distributed into three treat-
ments as follows: (T1) control: after selection, COCs were immedi-
ately washed; (T2) 0 MbCD: COCs were incubated for 1 h without
MbCD and exposed to 4 C for 30 min; (T3) 2 MbCD: COCs were
incubated for 1 h in the presence of 2 mg/mL of MbCD and exposed
to 4 C for 30 min. Following all treatments, oocytes were trans-
ferred to maturation medium.
After maturation, oocytes were either ﬁxed for evaluation of nu-
clear staining or fertilized in vitro for culturing until the blastocyst
stage. For all treatments, embryos were evaluated on D2, D6, D7
and D8 pi to determine cleavage and blastocyst rates.
Experiment 3. Developmental capacity of vitriﬁed immature
oocytes exposed to MbCD prior to vitriﬁcation
To evaluate the effect of MbCD exposure prior to vitriﬁcation in
immature bovine oocytes, COCs were distributed into fourtreatments as follows: (T1) control group: after selection, COCs
were immediately washed; (T2) vitriﬁed exposed to MbCD: COCs
were incubated for 1 h in the presence of 2 mg/mL of MbCD, vitri-
ﬁed and warmed; (T3) vitriﬁed not exposed to MbCD: COCs were
incubated for 1 h without MbCD, vitriﬁed and warmed; (T4) bench
control: COCs remained at room temperature during the time COC
from T2 and T3 were manipulated. Following all treatments, oo-
cytes were transferred to maturation medium.
After maturation, oocytes were either ﬁxed for evaluation of nu-
clear staining or fertilized in vitro for culturing until the blastocyst
stage. For all treatments, embryos were evaluated on D2, D6, D7
and D8 pi to determine cleavage and blastocyst rates.
To evaluate fertilization rates, a group of oocytes were removed
from culture at 18 h pi, ﬁxed, stained and examined by phase con-
trast microscopy.
Statistical analysis
Data were analyzed by Chi-square testing with a signiﬁcance le-
vel of 5% (P < 0.05).Results
Experiment 1
Table 1 shows nuclear maturation rates of bovine immature oo-
cytes exposed to different concentrations of MbCD and submitted
to cold stress for 10 min. A lower percentage (P < 0.05) of oocytes
(all groups) exposed to cold stress reached MII after 24 h of matu-
ration compared to control and bench control groups. The oocytes
that remained on the bench while the groups were submitted to
cold stress showed a similar nuclear maturation rate (P > 0.05) rel-
ative to the control group but had a higher percentage of abnormal
chromatin (P > 0.05). Although cold stress increased the percentage
of oocytes with degenerated chromatin, exposure to MbCD pro-
tected oocytes from degeneration (P > 0.05) (Table 1).
Embryo development, on D7 and D8, showed no difference
(P > 0.05) between oocytes in the control and bench control group
(Table 2). Both percentages were higher (P < 0.05) than those ob-
served for the groups exposed to cold stress and different concen-
trations of MbCD.
Experiment 2
To evaluate the protective effect of MbCD, the time of the cold
stress was increased from 10 to 30 min, after the treatment with
2 mg mL1. Only one concentration of MbCD was used. Data on nu-
clear maturation and embryo development are presented in Tables
3 and 4. No differences (P > 0.05) in the percentages of immature
oocytes were observed among groups. However, a higher percent-
age of oocytes reached MII in the control group (P < 0.05) relative
to the treated groups. The exposure of oocytes to MbCD decreased
the percentage of oocytes that degenerated due to cold stress.
Regardless, oocytes exposed to MbCD and submitted to cold stress
for 30 min had lower (P < 0.05) cleavage and blastocyst rates than
the control group.
Experiment 3
The results are depicted in Tables 5–7. Vitriﬁcation and expo-
sure to MbCD altered the percentage of oocytes that reached MII
and the percentage of degenerated oocytes after in vitro matura-
tion (Table 5). Oocytes vitriﬁed after exposing to 2 mg of MbCD
showed higher percentages (P < 0.05) of MII oocytes and lower
(P < 0.05) rates of degeneration compared to unexposed cells
Table 1
Effect of methyl-b-cyclodextrin (MbCD) on the nuclear maturation of bovine immature oocytes exposed to cold stress (CS) for 10 min at 4C.
Oocyte treatment N Stages of meiosis
Immature n (%) Metaphase II n (%) Abnormal n (%) Degenerate n (%)
Control 102 12 (11.7)b 78 (76.4)a 5 (4.9)a 7 (6.8)a
0 mg/ml MbCD + CS 114 2 (1.7)a 33 (28.9)b 18 (15.7)b,c 61 (53.5)c
1 mg/ml MbCD + CS 98 7 (7.1)a,b 35 (35.7)b 23 (23.4)b,c,d 33 (33.6)b
2 mg/ml MbCD + CS 97 5 (5.1)a 37 (38.1)b 25 (25.7)c,d 30 (30.9)b
3 mg/ml MbCD + CS 92 6 (6.5)a,b 27 (29.3)b 25 (27.1)d 34 (36.9)b
Bench control 91 7 (7.6)b 58 (63.7)a 13 (14.2)b 13 (14.2)a
a,b,c,d Values with different superscripts in the same column are signiﬁcantly different (P < 0.05).
Table 2
Cleavage and blastocyst rates for bovine immature oocytes exposed to different concentrations of methyl-b-cyclodextrin (MbCD) and submitted to cold stress (CS) for 10 min at
4 C.
Oocyte treatment N Cleaved, D2 n (% ± S.D.) Blastocyst, D7 n (% ± S.D.) Blastocyst, D8 n (% ± S.D.)
Control 181 142 (78.4 ± 13.6)a 63 (34.8 ± 6.1)a 70 (38.7 ± 7.7)a
0 mg MbCD + CS 113 61 (53.9 ± 6.1)b 15 (13.3 ± 2.0)b 16 (14.2 ± 1.9)b
1 mg MbCD + CS 133 67 (50.4 ± 8.1)b 12 (9.0 ± 2.1)b,c 13 (9.8 ± 2.8)b,c
2 mg MbCD + CS 116 62 (53.4 ± 5.0)b 14 (12.1 ± 1.4)b 14 (12.1 ± 1.1)b,c
3 mg MbCD + CS 135 65 (48.1 ± 8.2)b 13 (9.6 ± 1.5)b,c 16 (11.9 ± 1.9)b,c
Bench control 126 92 (73.0 ± 2.9)a 44 (34.9 ± 3.1)a 46 (36.5 ± 3.0)a
a,b,c Values with different superscripts in the same column are signiﬁcantly different (P < 0.05).
Table 3
Effect of methyl-b-cyclodextrin (MbCD) on the nuclear maturation of bovine immature oocytes exposed to cold stress (CS) for 30 min at 4 C.
Oocyte treatment N Stages of meiosis
Immature n (%) Metaphase II n (%) Abnormal n (%) Degenerate n (%)
Control 108 18 (16.6)a 79 (73.1)a 3 (2.7)a 8 (7.4)a
0 mg/ml MbCD + CS 101 10 (9.9)a 30 (29.7)b 15 (14.8)b 46 (45.5)c
2 mg/ml MbCD + CS 103 14 (13.5)a 40 (38.8)b 21 (20.3)b 28 (27.1)b
a,b,c Values with different superscripts in the same column are signiﬁcantly different (P < 0.05).
Table 4
Cleavage and blastocyst rates for bovine immature oocytes exposed to different concentrations of methyl-b-cyclodextrin (MbCD) and submitted to cold stress (CS) for 30 min at
4 C.
Oocyte treatment N Cleaved, D2 n (% ± S.D.) Blastocysts, D7 n (% ± S.D.) Blastocyst, D8 n (% ± S.D.)
Control 226 190 (84.1 ± 10.7)a 84 (37.2 ± 4.3)a 97 (42.9 ± 4.2)a
0 mg/ml MbCD + CS 205 71 (34.6 ± 6.9)b 13 (6.3 ± 2.5)b 16 (7.8 ± 2.8)b
2 mg/ml MbCD + CS 223 74 (33.2 ± 6.8)b 20 (9.0 ± 4.1)b 20 (8.9 ± 3.7)b
a,b,c Values with different superscripts in the same column are signiﬁcantly different (P < 0.05).
Table 5
Effect of MbCD on the nuclear maturation of bovine immature oocytes exposed to methyl-b-cyclodextrin (MbCD) and vitriﬁed (Vit).
Oocyte treatment N Stages of meiosis
Immature n (%) Metaphase II n (%) Abnormal n (%) Degenerate n (%)
Control 92 2 (2.1)a 72 (78.2)a 10 (10.8)a 8 (8.6)a
0 mg/ml MbCD + Vit 78 4 (5.1)a,b 23 (29.4)c 13 (16.6)a 38 (48.7)c
2 mg/ml of MbCD + Vit 74 2 (2.7)a,b 34 (45.9)b 14 (18.9)a 24 (32.4)b
Bench control 87 8 (9.1)b 57 (65.5)a 10 (11.4)a 12 (13.7)a
a,b,c Values with different superscripts in the same column are signiﬁcantly different (P < 0.05).
Table 6
Cleavage and blastocyst rates for bovine immature oocytes exposed to methyl-b-cyclodextrin (MbCD) and vitriﬁed (Vit).
Oocyte treatment N Cleaved, D2 n (% ± S.D.) Blastocysts, D7 n (% ± S.D.) Blastocyst, D8 n (% ± S.D.)
Control 181 147 (81.2 ± 1.4)a 63 (34.8 ± 0.8)a 68 (37.5 ± 0.8)a
0 mg/ml MbCD + Vit 121 27 (22.3 ± 2.0)b 1 (0.8 ± 0.4)c 3 (2.4 ± 0.8)b
2 mg/ml MbCD + Vit 131 32 (24.4 ± 2.2)b 7 (5.3 ± 0.8)b 7 (5.3 ± 0.8)b
Bench control 183 137 (74.8 ± 2.5)a 52 (28.4 ± 1.4)a 59 (32.2 ± 1.8)a
a,b,c Values with different superscripts in the same column are signiﬁcantly different (P < 0.05).
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Table 7
Fertilization rates for immature oocytes exposed to methyl-b-cyclodextrin (MbCD) and vitriﬁed (Vit).
Oocyte treatment N Non Fertilized n (%) Fertilized n (%) Degenerated n (%) Abnormal n (%)
Control 91 14 (15.3)b 70 (76.9)a 3 (3.2)a 4 (4.3)a
0 mg/ml MbCD + Vit 88 7 (7.9)b 19 (21.5)c 45 (51.1)c 17 (19.3)b
2 mg/ml MbCD + Vit 85 1 (1.1)a 28 (32.9)c 44 (51.7c 12 (14.1)b
Bench control 95 16 (16.8)b 58 (61.0)b 16 (16.8)b 5 (5.2)a
a,b,c Values with different superscripts in the same column are signiﬁcantly different (P < 0.05).
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fertilization and development in vitro (Tables 6 and 7). Regardless
of MbCD concentration, vitriﬁed oocytes exhibited lower (P < 0.05)
cleavage and blastocyst rates than controls. Although at D8 the
blastocyst rate was similar for both groups with vitriﬁed stress,
an increase in the blastocyst rate at D7 was observed in vitriﬁed
oocytes that were exposed to MbCD prior to vitriﬁcation (Table 6).
When the fertilization capacity was evaluated in vitriﬁed oo-
cytes, it was observed that the group not exposed to MbCD showed
the lowest percentage (P < 0.05) of non-fertilized oocytes at 18 h pi.
Both vitriﬁed groups had lower rates (P < 0.05) of fertilization and
higher (P < 0.05) percentages of degenerate and abnormal chroma-
tin oocytes relative to the control groups (Table 7). Compared to
control, it was observed that the bench group presented lower
fertilization rates (P < 0.05) and higher percentages (P < 0.05) of
degenerated oocytes (Table 7).Discussion
The main limiting factor for achieving optimal cryopreservation
of oocytes is their high sensitivity to cooling injuries. Among cellu-
lar components, the plasma membrane is usually described as one
of the most affected structures during the cryopreservation process
[3,40]. This sensitivity to cooling is determined by the membrane
phospholipid composition and membrane cholesterol: phospho-
lipid ratio [3,10,30,31,40,41]. When cholesterol is added to the cell
membrane, ﬂuidity is more easily achieved [3], which leads to
higher resistance to cold stress. In fact, the manipulation of the
plasma membrane lipid proﬁle by increasing the cholesterol con-
centration in sperm [1,25,26,41] and oocyte [10,30,41] membranes
has resulted in a reduction of cell damage after cryopreservation.
In the present study, we attempted to add cholesterol to the oo-
cyte plasma membrane using MbCD as a vehicle. We aimed to in-
crease the cholesterol: phospholipid rate to improve oocyte
vitriﬁcation results. For our approach, we loaded MbCD with cho-
lesterol removed from FCS by incubating it overnight in a medium
enriched with serum. After incubation, MbCD loaded with choles-
terol was added to medium containing the immature bovine oo-
cytes, which were then exposed to cold treatments and assessed
for cytoplasmic as well as nuclear viability.
In the ﬁrst experiment, different concentrations of MbCD were
tested to determine if it could protect oocytes during their expo-
sure to a 4 C cold stress for 10 min. It was very clear that this dura-
tion of exposure was sufﬁcient to affect oocyte viability and cause a
subsequent decrease in nuclear and cytoplasmic maturation as
well as an increase in degenerated oocytes. These results were sim-
ilar to those observed by Wu et al. Wu et al. [39] who demon-
strated that storing bovine immature oocytes at 4 C for 10 min
substantially reduced their maturation and cleavage rates. Our re-
sults also showed that short MbCD exposure did not effectively
protect oocytes against cold stress, as different concentrations
did not increase the percentage of oocytes that reached MII by
the end of the maturation period. However, it is worth mentioning
that the MbCD-treated groups displayed a reduction in oocytes
with degenerated chromatin. These results indicate that cyclodex-trin might positively affect oocytes. Similar to nuclear maturation,
the exposure to MbCD treatments did not improve either the cleav-
age rate or blastocyst production.
To analyze whether the time of exposure to cold stress in the
ﬁrst experiment was insufﬁcient to detect the effect of MbCD, a
second experiment was designed that increased the exposure time
to cold stress from 10 to 30 min. Because no differences were ob-
served with the different concentrations of MbCD, an intermediate
concentration of 2 mg/mL was used. The amount of time of cold
stress exposure in oocytes did not seem to be the main cause of
the cold-related damage, as increasing the time did not alter the
rate of MII oocytes after IVM. Oocyte maturation was still signiﬁ-
cantly affected, regardless of the presence of MbCD, when the tem-
perature was reduced to 4 C even for a short period of time.
Treatment with MbCD did not protect oocytes nor improve the
maturation rates of the nucleus or cytoplasm.
Finally, we tested the effect of MbCD on oocytes prior to vitriﬁ-
cation. Oocytes incubated with or without cholesterol-loaded
MbCD were vitriﬁed and subsequently matured, fertilized and cul-
tured in vitro. In this experiment, MbCD lowered the percentage of
oocytes that underwent degeneration, while a higher percentage of
oocytes reached MII stage. This beneﬁcial effect was not observed
in our previous experiment when oocytes were exposed to 4 C
temperature but not vitriﬁcation. It is possible that very rapid cool-
ing, such as that performed with the cryotop method, minimizes
the time spent at the critical temperature and circumvents the del-
eterious effect of cold stress. Thus, the beneﬁcial effect of cell
membrane stabilization by MbCD could protect the oocytes’ struc-
tures, which allows them to reach metaphase II.
As expected [12,21,22,38,42], vitriﬁcation negatively affected
the developmental ability of oocytes, and no effect was observed
after the MbCD treatment in terms of cleavage and blastocyst rates.
Although Horvarth and Seidel [10] found signiﬁcant differences in
cleavage and eight cell embryos when loaded MbCD was used,
these variations gradually disappeared by the blastocyst stage.
While day 8 blastocyst rates were similar among vitriﬁed oo-
cytes, higher blastocyst rates at D7 were observed in oocytes ex-
posed to MbCD. It is well established that the speed of
development is related to embryo quality; thus, it is possible that
the quality of embryos was better. Since there was no signiﬁcant
difference in D8 blastocysts rates, developmental delay indicates
a lower embryonic viability [15]. One approach to conﬁrm the
quality of the embryos would be to perform other evaluations,
such as embryo cell counting [10], differential staining and gene
expression assays [2,7,32].
While the nuclear maturation of vitriﬁed oocytes was improved
by MbCD, there was no change in blastocyst rate. It is difﬁcult to
understand the full impact of this data because there is scarce
precedent in the available literature on MbCD pretreatment. How-
ever, rationales can be constructed to explain the lack of a beneﬁ-
cial effect. One possibility is that we used a alternate approach for
loading MbCD with cholesterol by incubating it with FCS, while
previous groups used MbCD that was already loaded with choles-
terol [10]. Potentially, our FCS incubation did not effectively load
MbCD with cholesterol; thus, no cholesterol was incorporated into
the membrane. The direct isolation of cholesterol incorporation
324 J.F.W. Sprícigo et al. / Cryobiology 65 (2012) 319–325sites in oocytes could answer these questions. An alternative
explanation is that MbCD decreased damage to the plasma mem-
brane, possibly supported by the lower degeneration rate, but did
not prevent damage to other regions that have a higher impact on
oocyte viability.
During oocyte maturation, cytoplasmic organelles undergo vari-
ous remodeling and redistribution processes [8,36]. Vitriﬁcation has
been reported to affect someof those events. Among organelles, cor-
tical granules are seriously affected [11,21]. Normally after IVM,
cortical granules exhibit a peripheral distribution, while vitriﬁed
oocytes display a clustered distribution. This alteration could impair
fertilization and compromise embryonic development. In addition,
studies show that cryopreservation of mouse oocytes can cause
zone hardening [14], which can also impair fertilization. To ensure
that low cleavage rates were not due to difﬁculties in sperm pene-
tration, we evaluated the fertilization process. The results showed
that MbCD pretreatment did not beneﬁt vitriﬁed oocytes compared
to vitriﬁed oocytes without MbCD pretreatment. A majority of the
oocytes were already degenerated by the time fertilization oc-
curred. These results suggested that besides plasma membrane
other sites also important for oocyte viability can be affected by this
technique. Potential sites of damage include regions related to nu-
clearmaturation and retention of the polar body [17], chromosomal
aberrations [6], multidirectional or meiotic spindle disorganization
[4,16,34], mitochondrial and cortical granules distribution, and
alterations in gene expression [2,6,7].
The results presented here suggest that more research is re-
quired to clarify whether MbCD is beneﬁcial to the oocyte plasma
membrane as well as to determine its optimal dose and time of
exposure prior to cryopreservation. This information is vital for
optimizing the use of this procedure to improve oocyte viability
after vitriﬁcation because it can be used in association with other
substances or procedures that would protect other cell structures
from cold-related damage.
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